Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

French ATU granted for Vimizim in Morquio A syndrome

Nov. 18, 2013

MicroBiome Therapeutics advances development of NM-504

Nov. 15, 2013

Adocia begins trial of combination of long- and fast-acting insulin analogues

Nov. 15, 2013

Researchers at Novartis present novel DGAT1 inhibitors

Nov. 14, 2013

Palatin enters into license option agreement for bremelanotide in Europe

Nov. 14, 2013

Researchers identify novel small-molecule adiponectin receptor agonist for diabetes and obesity

Nov. 14, 2013

Ligand begins phase I trial of LGD-6972 for type 2 diabetes

Nov. 13, 2013

Patisiran receives FDA fast track designation for TTR-mediated amyloidosis

Nov. 13, 2013

GSK reports topline results from phase III study of darapladib in chronic coronary heart disease

Nov. 12, 2013

Ohr Pharmaceutical patents novel PTP-1B inhibitors

Nov. 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...